Put Inhaled and Oral COVID-19 Treatments in Perspective

April 2021

You’ll hear buzz about whether to use inhaled corticosteroids, colchicine, or fluvoxamine in OUTpatients with COVID-19.

Inhaled steroids and oral colchicine are of interest for their anti-inflammatory effects...and fluvoxamine may regulate cytokines.

But emphasize that it’s too soon to prescribe any of these meds or other oral “cocktails” to treat COVID-19. Overall data are limited...and some studies aren’t peer-reviewed or published yet.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote